Diagnostic Cartridge Field Diagnostic System Market Size & Share Type (Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Electrolytes Testing); End-user (Specialty Clinics, Laboratory, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3936
  • Published Date: May 30, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Diagnostic Cartridge Field Diagnostic System Market size is anticipated to reach USD 12 Billion by the end of 2035, , growing at a CAGR of 5% during the forecast period i.e., 2023-2035. In the year 2022, the industry size of diagnostic cartridge field diagnostic systems was USD 7 Billion. The uptrend of point-of-care diagnostics or near-patient testing to avail accurate, precise, and timely results will thrust the market growth.

Diagnostic field system refers to the detection of the amount of or an analyte in body fluids or tissue that affects the pathogenesis of any disease. It helps as a biological marker shown to indicate a predisposition to any disease. The field is gaining importance with the increasingly deteriorating lifestyle of the global population, diminishing immunity globally.


Diagnostic Cartridge Field Diagnostic System Market
Get more information on this report: Request Free Sample PDF

Diagnostic Cartridge Field Diagnostic System Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Prevalence of Chronic and Acute Diseases – Diseases such as diabetes, cardiac disorders, and cancer are now prevailing amongst people worldwide at a higher rate. This has emerged in the importance of a cartridge-based diagnostic market. According to the data from the World Health Organization (WHO), nearly 1.6 million deaths are caused by diabetes, and nearly 17.9 million deaths are caused by cardiovascular diseases worldwide every year.
  • Increasing Importance of the Diagnostic Industry - The increasing demand for testing, quick results, and accurate diagnosis is leading to the adoption of technology and has further brightened the future of the smart diagnostic and monitoring medical device market. Moreover, augmenting awareness about preventive healthcare is poised to fuel market growth.

Challenges

  • Challenge of Quality Control and Result Reporting - the improper quality check protocols and incomplete reporting of results hamper the growth of the market.
  • Lack of Accuracy due to Test Error
  • Slower Penetration

Diagnostic Cartridge Field Diagnostic System Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~5%

Base Year Market Size (2022)

~ USD 7 Billion

Forecast Year Market Size (2035)

~ USD 12 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Diagnostic Cartridge Field Diagnostic System Segmentation

Type (Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Electrolytes Testing)

The cardiac markers testing segment is slated to hold 40% share of the global diagnostic cartridge field diagnostic system market by 2035. The increasing cases of myocardial infarction (MI), commonly known as a heart attack can be predicted earlier with cardiac marker tests that identify blood chemicals associated with myocardial infarction. As per findings, in the United States, nearly at every 40 seconds someone suffers from a heart attack.

End-User (Specialty Clinics, Laboratory, Hospitals)

The hospital segment is anticipated to account for around 40% revenue share by 2035, owing to the rising advancements in diagnostic activities in the hospital setting. Increasing the use of handheld/ portable diagnostics devices is also propelling the market growth.

Further, healthcare practitioners also collect a blood sample from the patient and send this sample to a satellite lab for quick results due to the increasing volume of diagnoses that need to be performed in hospitals.

Our in-depth analysis of the global market includes the following segments:

  Type

  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Electrolytes Testing

  End User

  • Specialty Clinics
  • Laboratory
  • Hospitals

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Diagnostic Cartridge Field Diagnostic System Industry - Regional Synopsis

APAC Market Statistics

The Asia Pacific region is set to hold 35% diagnostic cartridge field diagnostic systems market share by 2035. The increasing spread of disease in the region is resulting in several collaborations between corporates and multinational companies to uplift the overall diagnostic market. This is expected to pool investment in the diagnostic cartridge field diagnostic system market.

The cost-effective, hassle-free, and quality treatment options with superior diagnostic services available at low prices in countries such as India which is fast emerging as a medical tourism hub are also garnering more growth. India recorded a footfall of around 6.19 million foreign tourists in 2022, which was 4 times more compared with ~1.52 million in 2021.

North American Market Forecast

North America diagnostic cartridge field diagnostic system market is estimated to register a share of about 25% till 2035. The rapid adoption of advanced medical technology in the region especially with the rising total spending in the healthcare sector is estimated to back the market expansion.

World Bank revealed that ~16% of the total GDP of the North American region was spent on healthcare. Adding to it, the immense research by giant players to develop accurate testing tools is also estimated to boost market growth.

Research Nester
Diagnostic Cartridge Field Diagnostic System Market Share
Get more information on this report: Request Free Sample PDF

Companies dominating the Diagnostic Cartridge Field Diagnostic System Landscape

top-features-companies
    • Siemens Healthineers AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Bio-Rad Laboratories, Inc.
    • Sysmex Corporation
    • Arkray Inc.
    • Becton, Dickinson, and Company
    • Binx Health Limited
    • Nova Biomedical Corporation

In-the-news

In The News

  • ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc., and Shionogi announced the approval of the U.S. Food and Drug Administration (FDA) for Cabotegravir, an antiviral drug.
  • Danaher Corporation announced the acquisition of Aldevron, to expand Danaher's life sciences segment.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3936
  • Published Date: May 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing prevalence of chronic and acute diseases is anticipated to be major growth drivers of the market.

The market size of diagnostic cartridge field diagnostic system is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023-2035.

The challenge of slower penetration due to challenges of quality control and result reporting are estimated to be the growth hindering factors for the market expansion.

The market in the APAC region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Arkray Inc., Becton, Dickinson and Company, Binx Health Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, end-user and by region.

The cardiac markers testing segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Diagnostic Cartridge Field Diagnostic System Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying